Correlation between expression of EGFR and the prognosis of patients with cervical carcinoma

YoungTae Kim, Sang Won Park, Jae Wook Kim

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Objective. Overexpression of epidermal growth factor receptor (EGFR) gene has been detected in a large number of human tumors, in most of which the association between overexpression of EGFR and poor prognosis of the disease has been reported. However, the prognostic role of EGFR oncoprotein in cervical carcinoma remains controversial. The current study aimed to determine the prognostic value of EGFR in patients with cervical cancer. Methods. We measured EGFR oncoprotein with an enzyme-linked immunosorbent assay (ELISA). Results were correlated to clinical data. Results. The presence of measurable levels of EGFR in the tumor was found in all of the explored tumors. The levels varied widely from 31 to 2874 fmol/mg protein with a median at 582 fmol/mg protein, and Q1, Q2, and Q3 quartiles were 156, 562, and 1047, respectively. Overexpression of EGFR was associated with an impaired prognosis with respect to disease-free interval (P = 0.03) and overall survival (P = 0.04). Multivariate analysis revealed that tumor EGFR provided prognostic information with respect to disease-free interval (P = 0.002) and overall survival (P = 0.005) independently of the two established prognosticators, FIGO stage and lesion size. Conclusion. Our results are consistent with the concept that EGFR confers prognostic information in addition to that provided by the established clinicopathologic parameters of FIGO stage and lesion size.

Original languageEnglish
Pages (from-to)84-89
Number of pages6
JournalGynecologic Oncology
Volume87
Issue number1
DOIs
Publication statusPublished - 2002 Jan 1

Fingerprint

Epidermal Growth Factor Receptor
Carcinoma
Oncogene Proteins
Neoplasms
erbB-1 Genes
Survival
Uterine Cervical Neoplasms
Proteins
Multivariate Analysis
Enzyme-Linked Immunosorbent Assay

All Science Journal Classification (ASJC) codes

  • Oncology
  • Obstetrics and Gynaecology

Cite this

@article{81119086ecf341a68b4e2257b24bed95,
title = "Correlation between expression of EGFR and the prognosis of patients with cervical carcinoma",
abstract = "Objective. Overexpression of epidermal growth factor receptor (EGFR) gene has been detected in a large number of human tumors, in most of which the association between overexpression of EGFR and poor prognosis of the disease has been reported. However, the prognostic role of EGFR oncoprotein in cervical carcinoma remains controversial. The current study aimed to determine the prognostic value of EGFR in patients with cervical cancer. Methods. We measured EGFR oncoprotein with an enzyme-linked immunosorbent assay (ELISA). Results were correlated to clinical data. Results. The presence of measurable levels of EGFR in the tumor was found in all of the explored tumors. The levels varied widely from 31 to 2874 fmol/mg protein with a median at 582 fmol/mg protein, and Q1, Q2, and Q3 quartiles were 156, 562, and 1047, respectively. Overexpression of EGFR was associated with an impaired prognosis with respect to disease-free interval (P = 0.03) and overall survival (P = 0.04). Multivariate analysis revealed that tumor EGFR provided prognostic information with respect to disease-free interval (P = 0.002) and overall survival (P = 0.005) independently of the two established prognosticators, FIGO stage and lesion size. Conclusion. Our results are consistent with the concept that EGFR confers prognostic information in addition to that provided by the established clinicopathologic parameters of FIGO stage and lesion size.",
author = "YoungTae Kim and Park, {Sang Won} and Kim, {Jae Wook}",
year = "2002",
month = "1",
day = "1",
doi = "10.1006/gyno.2002.6803",
language = "English",
volume = "87",
pages = "84--89",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "1",

}

Correlation between expression of EGFR and the prognosis of patients with cervical carcinoma. / Kim, YoungTae; Park, Sang Won; Kim, Jae Wook.

In: Gynecologic Oncology, Vol. 87, No. 1, 01.01.2002, p. 84-89.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Correlation between expression of EGFR and the prognosis of patients with cervical carcinoma

AU - Kim, YoungTae

AU - Park, Sang Won

AU - Kim, Jae Wook

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Objective. Overexpression of epidermal growth factor receptor (EGFR) gene has been detected in a large number of human tumors, in most of which the association between overexpression of EGFR and poor prognosis of the disease has been reported. However, the prognostic role of EGFR oncoprotein in cervical carcinoma remains controversial. The current study aimed to determine the prognostic value of EGFR in patients with cervical cancer. Methods. We measured EGFR oncoprotein with an enzyme-linked immunosorbent assay (ELISA). Results were correlated to clinical data. Results. The presence of measurable levels of EGFR in the tumor was found in all of the explored tumors. The levels varied widely from 31 to 2874 fmol/mg protein with a median at 582 fmol/mg protein, and Q1, Q2, and Q3 quartiles were 156, 562, and 1047, respectively. Overexpression of EGFR was associated with an impaired prognosis with respect to disease-free interval (P = 0.03) and overall survival (P = 0.04). Multivariate analysis revealed that tumor EGFR provided prognostic information with respect to disease-free interval (P = 0.002) and overall survival (P = 0.005) independently of the two established prognosticators, FIGO stage and lesion size. Conclusion. Our results are consistent with the concept that EGFR confers prognostic information in addition to that provided by the established clinicopathologic parameters of FIGO stage and lesion size.

AB - Objective. Overexpression of epidermal growth factor receptor (EGFR) gene has been detected in a large number of human tumors, in most of which the association between overexpression of EGFR and poor prognosis of the disease has been reported. However, the prognostic role of EGFR oncoprotein in cervical carcinoma remains controversial. The current study aimed to determine the prognostic value of EGFR in patients with cervical cancer. Methods. We measured EGFR oncoprotein with an enzyme-linked immunosorbent assay (ELISA). Results were correlated to clinical data. Results. The presence of measurable levels of EGFR in the tumor was found in all of the explored tumors. The levels varied widely from 31 to 2874 fmol/mg protein with a median at 582 fmol/mg protein, and Q1, Q2, and Q3 quartiles were 156, 562, and 1047, respectively. Overexpression of EGFR was associated with an impaired prognosis with respect to disease-free interval (P = 0.03) and overall survival (P = 0.04). Multivariate analysis revealed that tumor EGFR provided prognostic information with respect to disease-free interval (P = 0.002) and overall survival (P = 0.005) independently of the two established prognosticators, FIGO stage and lesion size. Conclusion. Our results are consistent with the concept that EGFR confers prognostic information in addition to that provided by the established clinicopathologic parameters of FIGO stage and lesion size.

UR - http://www.scopus.com/inward/record.url?scp=0036920080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036920080&partnerID=8YFLogxK

U2 - 10.1006/gyno.2002.6803

DO - 10.1006/gyno.2002.6803

M3 - Article

VL - 87

SP - 84

EP - 89

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -